186 related articles for article (PubMed ID: 23075769)
21. Redirecting Pseudomonas exotoxin.
FitzGerald D; Pastan I
Semin Cell Biol; 1991 Feb; 2(1):31-7. PubMed ID: 1954341
[TBL] [Abstract][Full Text] [Related]
22. Injection of Pseudomonas aeruginosa Exo toxins into host cells can be modulated by host factors at the level of translocon assembly and/or activity.
Verove J; Bernarde C; Bohn YS; Boulay F; Rabiet MJ; Attree I; Cretin F
PLoS One; 2012; 7(1):e30488. PubMed ID: 22299042
[TBL] [Abstract][Full Text] [Related]
23. Anti-Mesothelin Recombinant Immunotoxin Therapy for Colorectal Cancer.
Cerise A; Bera TK; Liu X; Wei J; Pastan I
Clin Colorectal Cancer; 2019 Sep; 18(3):192-199.e1. PubMed ID: 31345777
[TBL] [Abstract][Full Text] [Related]
24. Engineering of bacterial exotoxins for highly efficient and receptor-specific intracellular delivery of diverse cargos.
Ryou JH; Sohn YK; Hwang DE; Park WY; Kim N; Heo WD; Kim MY; Kim HS
Biotechnol Bioeng; 2016 Aug; 113(8):1639-46. PubMed ID: 26773973
[TBL] [Abstract][Full Text] [Related]
25. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
[TBL] [Abstract][Full Text] [Related]
26. Developing a Novel Gene-Delivery Vector System Using the Recombinant Fusion Protein of Pseudomonas Exotoxin A and Hyperthermophilic Archaeal Histone HPhA.
Deng X; Zhang G; Zhang L; Feng Y; Li Z; Wu G; Yue Y; Li G; Cao Y; Zhu P
PLoS One; 2015; 10(11):e0142558. PubMed ID: 26556098
[TBL] [Abstract][Full Text] [Related]
27. Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo.
Sokolova E; Proshkina G; Kutova O; Shilova O; Ryabova A; Schulga A; Stremovskiy O; Zdobnova T; Balalaeva I; Deyev S
J Control Release; 2016 Jul; 233():48-56. PubMed ID: 27178808
[TBL] [Abstract][Full Text] [Related]
28. Ocular distribution of the chimeric protein IL2-PE40.
BenEzra D; Maftzir G; Hochberg E; Anteby I; Lorberboum-Galski H
Curr Eye Res; 1995 Feb; 14(2):153-8. PubMed ID: 7768107
[TBL] [Abstract][Full Text] [Related]
29. Translocation mediated by domain II of Pseudomonas exotoxin A: transport of barnase into the cytosol.
Prior TI; FitzGerald DJ; Pastan I
Biochemistry; 1992 Apr; 31(14):3555-9. PubMed ID: 1567815
[TBL] [Abstract][Full Text] [Related]
30. Intracellular delivery of therapeutic antibodies into specific cells using antibody-peptide fusions.
Gaston J; Maestrali N; Lalle G; Gagnaire M; Masiero A; Dumas B; Dabdoubi T; Radošević K; Berne PF
Sci Rep; 2019 Dec; 9(1):18688. PubMed ID: 31822703
[TBL] [Abstract][Full Text] [Related]
31. The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo.
Sarac MS; Cameron A; Lindberg I
Infect Immun; 2002 Dec; 70(12):7136-9. PubMed ID: 12438396
[TBL] [Abstract][Full Text] [Related]
32. HER2-affitoxin: a potent therapeutic agent for the treatment of HER2-overexpressing tumors.
Zielinski R; Lyakhov I; Hassan M; Kuban M; Shafer-Weaver K; Gandjbakhche A; Capala J
Clin Cancer Res; 2011 Aug; 17(15):5071-81. PubMed ID: 21791637
[TBL] [Abstract][Full Text] [Related]
33. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa].
Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA
Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999
[TBL] [Abstract][Full Text] [Related]
34. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
[TBL] [Abstract][Full Text] [Related]
35. Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A.
Yates SP; Merrill AR
Biochem J; 2004 May; 379(Pt 3):563-72. PubMed ID: 14733615
[TBL] [Abstract][Full Text] [Related]
36. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.
Hung CF; Cheng WF; Hsu KF; Chai CY; He L; Ling M; Wu TC
Cancer Res; 2001 May; 61(9):3698-703. PubMed ID: 11325841
[TBL] [Abstract][Full Text] [Related]
37. Selective staining and eradication of cancer cells by protein-carrying DARPin-functionalized liposomes.
Deyev S; Proshkina G; Baryshnikova O; Ryabova A; Avishai G; Katrivas L; Giannini C; Levi-Kalisman Y; Kotlyar A
Eur J Pharm Biopharm; 2018 Sep; 130():296-305. PubMed ID: 29959035
[TBL] [Abstract][Full Text] [Related]
38. Studies on the activity of barnase toxins in vitro and in vivo.
Prior TI; Kunwar S; Pastan I
Bioconjug Chem; 1996; 7(1):23-9. PubMed ID: 8741987
[TBL] [Abstract][Full Text] [Related]
39. Processing of Pseudomonas aeruginosa exotoxin A is dispensable for cell intoxication.
Morlon-Guyot J; Méré J; Bonhoure A; Beaumelle B
Infect Immun; 2009 Jul; 77(7):3090-9. PubMed ID: 19380469
[TBL] [Abstract][Full Text] [Related]
40. Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancers.
Yao Q; Cao S; Li C; Mengesha A; Low P; Kong B; Dai S; Wei M
Biochem Biophys Res Commun; 2010 Jul; 398(3):413-9. PubMed ID: 20599713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
